SCHEMBL6961687

SCHEMBL6961687

Cc1ccc(S(=O)(O)=S)c(CC2CCCCC2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.41
TSHR P16473 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
CASP1 P29466 1/20 0.39
NPC1 O15118 5/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
RAB9A P51151 3/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952510 0.93 L3MBTL1 (0.35) EPHX2TSHRKMT2AMEN1TP53
SCHEMBL5802385 0.89 EPHX2 (0.42) EPHX2TSHRKMT2AMEN1TP53
SCHEMBL3389669 0.87 EPHX2 (0.40) EPHX2TSHRKMT2AMEN1TP53
SCHEMBL20573229 0.84 EPHX2 (0.38) EPHX2TSHRKMT2AMEN1NPC1
SCHEMBL9485617 0.76 PIK3CG (0.32) EPHX2TSHRKMT2AMEN1GAA
SCHEMBL6417418 0.76 AKR1C3 (0.36) EPHX2TSHRKMT2AMEN1GAA
SCHEMBL31413167 0.75 CEL (0.44) TSHRKMT2AMEN1TP53NPC1
SCHEMBL17748789 0.75 CEL (0.44) TSHRKMT2AMEN1TP53NPC1
SCHEMBL963562 0.75 NPC1 (0.42) EPHX2NPC1RAB9A
SCHEMBL6961692 0.75 ALDH1A1 (0.38) KMT2AMEN1GAAPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed